Common variants related to serum uric acid concentrations are associated with glucose metabolism and insulin secretion in a Chinese population

PLoS ONE

Volumn 10, Issue 1, 2015, Pages

  Sun, Xue ^a   Zhang, Rong ^a   Jiang, Feng ^a   Tang, Shanshan ^a   Chen, Miao ^a   Peng, Danfeng ^a   Yan, Jing ^a   Wang, Tao ^a   Wang, Shiyun ^a   Bao, Yuqian ^a   Hu, Cheng ^a   Jia, Weiping ^a  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CREATININE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITROGEN; TRIACYLGLYCEROL; UREA; URIC ACID; GLUCOSE;

ABCG2 GENE; ADULT; ARTICLE; BODY MASS; CHINA; CHINESE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DISEASE PREDISPOSITION; FEMALE; GCKR GENE; GENE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENOTYPE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HUMAN; INSULIN RELEASE; LIPOPROTEIN BLOOD LEVEL; LRP2 GENE; LRRC16A GENE; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NON INSULIN DEPENDENT DIABETES MELLITUS; PDZK1 GENE; RISK FACTOR; SF1 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SLC17A1 GENE; SLC17A3 GENE; SLC22A11 GENE; SLC22A12 GENE; SLC2A9 GENE; SYSTOLIC BLOOD PRESSURE; UREA NITROGEN BLOOD LEVEL; URIC ACID BLOOD LEVEL; AGED; BLOOD; DIABETES MELLITUS, TYPE 2; GENETIC PREDISPOSITION; GENETICS; GLUCOSE TOLERANCE TEST; METABOLISM; MIDDLE AGED; SECRETION (PROCESS);

ADULT; AGED; CHINA; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLUCOSE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; URIC ACID;

EID: 84921901903     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0116714     Document Type: Article

References (39)

1. Stumvoll M, Goldstein BJ, van Haeften TW (2005) Type 2 diabetes: principles of pathogenesis and therapy. Lancet 365: 1333-1346. doi: 10.1016/S0140-6736(05)61032-X PMID: 15823385
2. Kodama S, Saito K, Yachi Y, Asumi M, Sugawara A, et al (2009) Association between serum uric acid and development of type 2 diabetes. Diabetes Care 32: 1737-1742. doi: 10.2337/dc09-0288 PMID: 19549729
3. Modan M, Halkin H, Karasik A, Lusky A (1987) Elevated serum uric acid-a facet of hyperinsulinaemia. Diabetologia 30: 713-718. doi: 10.1007/BF00296994 PMID: 3322912
4. Jia Z, Zhang X, Kang S, Wu Y (2013) Serum uric acid levels and incidence of impaired fasting glucose and type 2 diabetes mellitus: A meta-analysis of cohort studies. Diabetes Res Clin Pract. doi: 10.1016/j. diabres.2013.03.026 PMID: 23608549
5. Fan HQ, Tang W, Wang ZX, Wang SJ, Qin YH, et al. (2013) Association of serum uric acid with 2-hour postload glucose in Chinese with impaired fasting plasma glucose and/or HbA1c. PLoS One 8: e67759. doi: 10.1371/journal.pone.0067759 PMID: 23844086
6. Ishizaka N, Ishizaka Y, Toda E, Nagai R, Yamakado M (2005) Association between serum uric acid, metabolic syndrome, and carotid atherosclerosis in Japanese individuals. Arterioscler Thromb Vasc Biol 25: 1038-1044. doi: 10.1161/01.ATV.0000161274.87407.26 PMID: 15746438
7. Roncal CA, Reungjui S, Sanchez-Lozada LG, Mu W, Sautin YY, et al. (2009) Combination of captopril and allopurinol retards fructose-induced metabolic syndrome. Am J Nephrol 30: 399-404. doi: 10.1159/000235731 PMID: 19696478
8. Zhang Y, Yamamoto T, Hisatome I, Li Y, Cheng W, et al. (2013) Uric acid induces oxidative stress and growth inhibition by activating adenosine monophosphate-activated protein kinase and extracellular signal-regulated kinase signal pathways in pancreatic beta cells. Mol Cell Endocrinol 375: 89-96. doi: 10.1016/j.mce.2013.04.027 PMID: 23707617
9. Jia L, Xing J, Ding Y, Shen Y, Shi X, et al. (2013) Hyperuricemia causes pancreatic beta-cell death and dysfunction through NF-kappaB signaling pathway. PLoS One 8: e78284. doi: 10.1371/journal.pone. 0078284 PMID: 24205181
10. Simental-Mendia LE, Rodriguez-Moran M, Guerrero-Romero F (2009) Failure of beta-cell function to compensate lack of insulin action in hyperuricemic subjects. Diabetes Metab Res Rev 25: 535-541. doi: 10.1002/dmrr.988 PMID: 19557736
11. Tang W, Fu Q, Zhang Q, Sun M, Gao Y, et al. (2014) The association between serum uric acid and residual beta-cell function in type 2 diabetes. J Diabetes Res 2014: 709691. doi: 10.1155/2014/709691 PMID: 24971368
12. Nath SD, Voruganti VS, Arar NH, Thameem F, Lopez-Alvarenga JC, et al. (2007) Genome scan for determinants of serum uric acid variability. J Am Soc Nephrol 18: 3156-3163. doi: 10.1681/ASN. 2007040426 PMID: 17978310
13. Liu WC, Hung CC, Chen SC, Lin MY, Chen LI, et al. (2011) The rs1014290 polymorphism of the SLC2A9 gene is associated with type 2 diabetes mellitus in Han Chinese. Exp Diabetes Res 2011: 527520. doi: 10.1155/2011/527520 PMID: 21584282
14. Sun X, Jiang F, Zhang R, Tang SS, Chen M, et al. (2014) Serum uric acid levels are associated with polymorphisms in the SLC2A9, SF1, and GCKR genes in a Chinese population. Acta Pharmacol Sin 35: 1421-1427. doi: 10.1038/aps.2014.87 PMID: 25283508
15. Jia WP, Pang C, Chen L, Bao YQ, Lu JX, et al. (2007) Epidemiological characteristics of diabetes mellitus and impaired glucose regulation in a Chinese adult population: the Shanghai Diabetes Studies, a cross-sectional 3-year follow-up study in Shanghai urban communities. Diabetologia 50: 286-292. doi: 10.1007/s00125-006-0503-1 PMID: 17180353
16. Bao Y, Ma X, Li H, Zhou M, Hu C, et al. (2010) Glycated haemoglobin A1c for diagnosing diabetes in Chinese population: cross sectional epidemiological survey. BMJ 340: c2249. doi: 10.1136/bmj.c2249 PMID: 20478961
17. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419. doi: 10.1007/BF00280883 PMID: 3899825
18. Stumvoll M, Van Haeften T, Fritsche A, Gerich J (2001) Oral glucose tolerance test indexes for insulin sensitivity and secretion based on various availabilities of sampling times. Diabetes Care 24: 796-797. doi: 10.2337/diacare.24.4.796 PMID: 11315860
19. Wang B, Meng D, Wang J, Liu S, Zhou S, et al. (2011) Genetic association of polymorphism rs1333049 with gout. Rheumatology (Oxford) 50: 1559-1561. doi: 10.1093/rheumatology/ker135
20. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. (2007) PLINK: a tool set for wholegenome association and population-based linkage analyses. Am J Hum Genet 81: 559-575. doi: 10.1086/519795 PMID: 17701901
21. Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, et al. (2010) New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 42: 105-116. doi: 10.1038/ng.520 PMID: 20081858
22. Hu C, Zhang R, Wang C, Yu W, Lu J, et al. (2010) Effects of GCK, GCKR, G6PC2 and MTNR1B variants on glucose metabolism and insulin secretion. PLoS One 5: e11761. doi: 10.1371/journal.pone. 0011761 PMID: 20668700
23. Kolz M, Johnson T, Sanna S, Teumer A, Vitart V, et al. (2009) Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations. PLoS Genet 5: e1000504. doi: 10.1371/journal.pgen.1000504 PMID: 19503597
24. van der Harst P, Bakker SJ, de Boer RA, Wolffenbuttel BH, Johnson T, et al. (2010) Replication of the five novel loci for uric acid concentrations and potential mediating mechanisms. Hum Mol Genet 19: 387-395. doi: 10.1093/hmg/ddp489 PMID: 19861489
25. Tin A, Woodward OM, Kao WH, Liu CT, Lu X, et al. (2011) Genome-wide association study for serum urate concentrations and gout among African Americans identifies genomic risk loci and a novel URAT1 loss-of-function allele. Hum Mol Genet 20: 4056-4068. doi: 10.1093/hmg/ddr307 PMID: 21768215
26. Sakiyama M, Matsuo H, Shimizu S, Nakashima H, Nakayama A, et al. (2014) A common variant of organic anion transporter 4 (OAT4/SLC22A11) gene is associated with renal underexcretion type gout. Drug Metab Pharmacokinet 29: 208-210. doi: 10.2133/dmpk.DMPK-13-NT-070 PMID: 24025986
27. Cha SH, Sekine T, Kusuhara H, Yu E, Kim JY, et al. (2000) Molecular cloning and characterization of multispecific organic anion transporter 4 expressed in the placenta. J Biol Chem 275: 4507-4512. doi: 10.1074/jbc.275.6.4507 PMID: 10660625
28. Ekaratanawong S, Anzai N, Jutabha P, Miyazaki H, Noshiro R, et al. (2004) Human organic anion transporter 4 is a renal apical organic anion/dicarboxylate exchanger in the proximal tubules. J Pharmacol Sci 94: 297-304. doi: 10.1254/jphs.94.297 PMID: 15037815
29. Orlando RA, Rader K, Authier F, Yamazaki H, Posner BI, et al. (1998) Megalin is an endocytic receptor for insulin. J Am Soc Nephrol 9: 1759-1766. PMID: 9773776
30. Nakayama A, Matsuo H, Shimizu T, Takada Y, Nakamura T, et al. (2014) Common variants of a urateassociated gene LRP2 are not associated with gout susceptibility. Rheumatol Int 34: 473-476. doi: 10.1007/s00296-013-2924-8 PMID: 24366390
31. Evans SA, Doblado M, Chi MM, Corbett JA, Moley KH (2009) Facilitative glucose transporter 9 expression affects glucose sensing in pancreatic beta-cells. Endocrinology 150: 5302-5310. doi: 10.1210/en. 2009-0747 PMID: 19808778
32. Keembiyehetty C, Augustin R, Carayannopoulos MO, Steer S, Manolescu A, et al. (2006) Mouse glucose transporter 9 splice variants are expressed in adult liver and kidney and are up-regulated in diabetes. Mol Endocrinol 20: 686-697. doi: 10.1210/me.2005-0010 PMID: 16293642
33. Roy D, Perreault M, Marette A (1998) Insulin stimulation of glucose uptake in skeletal muscles and adipose tissues in vivo is NO dependent. Am J Physiol 274: E692-699. PMID: 9575831
34. Duplain H, Burcelin R, Sartori C, Cook S, Egli M, et al. (2001) Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase. Circulation 104: 342-345. doi: 10.1161/01. CIR.104.3.342 PMID: 11457755
35. Sautin YY, Nakagawa T, Zharikov S, Johnson RJ (2007) Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress. Am J Physiol Cell Physiol 293: C584-596. doi: 10.1152/ajpcell.00600.2006 PMID: 17428837
36. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, et al. (2004) Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114: 1752-1761. doi: 10.1172/JCI21625 PMID: 15599400
37. Bhole V, Choi JW, Kim SW, de Vera M, Choi H (2010) Serum uric acid levels and the risk of type 2 diabetes: a prospective study. Am J Med 123: 957-961. doi: 10.1016/j.amjmed.2010.03.027 PMID: 20920699
38. Heni M, Ketterer C, Hart LM, Ranta F, van Haeften TW, et al. (2010) The impact of genetic variation in the G6PC2 gene on insulin secretion depends on glycemia. J Clin Endocrinol Metab 95: E479-484. doi: 10.1210/jc.2010-0860 PMID: 20826583
39. Heni M, Ketterer C, Thamer C, Herzberg-Schafer SA, Guthoff M, et al. (2010) Glycemia determines the effect of type 2 diabetes risk genes on insulin secretion. Diabetes 59: 3247-3252. doi: 10.2337/db10-0674 PMID: 20802253